Josep Redon

Summary

Affiliation: University of Valencia
Country: Spain

Publications

  1. ncbi Antioxidant activities and oxidative stress byproducts in human hypertension
    Josep Redon
    Department of Biochemistry and Molecular Biology, Medical School, University of Valencia, Avda Blasco Ibanez 17, 46010 Valencia, Spain
    Hypertension 41:1096-101. 2003
  2. ncbi Kidney function and cardiovascular disease in the hypertensive population: the ERIC-HTA study
    Josep Redon
    Hypertension Unit, Clinic Hospital of Valencia, Valencia University, Valencia, Spain
    J Hypertens 24:663-9. 2006
  3. doi The metabolic syndrome in hypertension: European society of hypertension position statement
    Josep Redon
    University of Valencia and CIBER 06 03 Physiopathology of Obesity and Nutrition, Institute of Health Carlos III, Madrid, Spain
    J Hypertens 26:1891-900. 2008
  4. doi Practical solutions to the challenges of uncontrolled hypertension: a white paper
    Josep Redon
    Hypertension Clinic, Internal Medicine, Hospital Clinico, University of Valencia, Valencia, Spain
    J Hypertens Suppl 26:S1-14. 2008
  5. ncbi Independent impact of obesity and fat distribution in hypertension prevalence and control in the elderly
    Josep Redon
    Hypertension Clinic, Hospital Clinico, University of Valencia, and CIBER of Obesity and Nutrition CB 03 06, Carlos III Institute of Health, Madrid, Spain
    J Hypertens 26:1757-64. 2008
  6. ncbi Prevalence and clinical characteristics of patients with true resistant hypertension in central and Eastern Europe: data from the BP-CARE study
    Gianmaria Brambilla
    aClinica Medica, Universita Milano Bicocca, Ospedale San Gerardo dei Tintori, Monza bIstituto Auxologico Italiano, Ospedale San Luca, Milan, Italy cCenter for Cardiovascular Prevention, Thomayer Hospital and Department of Preventive Cardiology, Institute of Clinical and Experimental Medicine, Prague, Czech Republic dPharmacology Department and INSERM U970 Hopital Europeen Georges Pompidou, Assistance Publique Hopitaux de Paris, Paris Derscartes University, France eDepartment of Hypertension and Diabetology, Medical University of Gdansk, Gdansk, Poland fInternal Medicine, Hospital Clinico, University of Valencia, Valencia, Spain gIRCCS MultiMedica, Sesto San Giovanni, Milan, Italy
    J Hypertens 31:2018-24. 2013
  7. ncbi Factors related to the impact of antihypertensive treatment in antioxidant activities and oxidative stress by-products in human hypertension
    Guillermo T Saez
    Department of Biochemistry and Molecular Biology, Medical School, Valencia, Spain
    Am J Hypertens 17:809-16. 2004
  8. doi Added impact of obesity and insulin resistance in nocturnal blood pressure elevation in children and adolescents
    Empar Lurbe
    Pediatric Department, Consorcio Hospital General, University of Valencia, Valencia, Spain
    Hypertension 51:635-41. 2008
  9. doi Polymorphisms of antioxidant enzymes, blood pressure and risk of hypertension
    Maria L Mansego
    Genotyping and Genetic Diagnosis Unit, Hospital Clínico Research Foundation and INCLIVA, Valencia, Spain
    J Hypertens 29:492-500. 2011
  10. doi Influence of concurrent obesity and low birth weight on blood pressure phenotype in youth
    Empar Lurbe
    Department of Pediatrics, Consorcio Hospital General, University of Valencia, Valencia, Spain
    Hypertension 53:912-7. 2009

Collaborators

Detail Information

Publications72

  1. ncbi Antioxidant activities and oxidative stress byproducts in human hypertension
    Josep Redon
    Department of Biochemistry and Molecular Biology, Medical School, University of Valencia, Avda Blasco Ibanez 17, 46010 Valencia, Spain
    Hypertension 41:1096-101. 2003
    ..In whole blood and in mononuclear cells from hypertensive subjects, there was an increase in oxidative stress and a reduction in the activity of antioxidant mechanisms that appeared to be independent of the blood pressure values...
  2. ncbi Kidney function and cardiovascular disease in the hypertensive population: the ERIC-HTA study
    Josep Redon
    Hypertension Unit, Clinic Hospital of Valencia, Valencia University, Valencia, Spain
    J Hypertens 24:663-9. 2006
    ....
  3. doi The metabolic syndrome in hypertension: European society of hypertension position statement
    Josep Redon
    University of Valencia and CIBER 06 03 Physiopathology of Obesity and Nutrition, Institute of Health Carlos III, Madrid, Spain
    J Hypertens 26:1891-900. 2008
    ..If a combination of drugs is required, low-dose diuretics can be used. A combination of thiazide diuretics and beta-blockers should be avoided...
  4. doi Practical solutions to the challenges of uncontrolled hypertension: a white paper
    Josep Redon
    Hypertension Clinic, Internal Medicine, Hospital Clinico, University of Valencia, Valencia, Spain
    J Hypertens Suppl 26:S1-14. 2008
    ....
  5. ncbi Independent impact of obesity and fat distribution in hypertension prevalence and control in the elderly
    Josep Redon
    Hypertension Clinic, Hospital Clinico, University of Valencia, and CIBER of Obesity and Nutrition CB 03 06, Carlos III Institute of Health, Madrid, Spain
    J Hypertens 26:1757-64. 2008
    ..Studies on the impact of weight excess and fat distribution on blood pressure are usually limited to young and middle-aged population, and data on the elderly are scarce...
  6. ncbi Prevalence and clinical characteristics of patients with true resistant hypertension in central and Eastern Europe: data from the BP-CARE study
    Gianmaria Brambilla
    aClinica Medica, Universita Milano Bicocca, Ospedale San Gerardo dei Tintori, Monza bIstituto Auxologico Italiano, Ospedale San Luca, Milan, Italy cCenter for Cardiovascular Prevention, Thomayer Hospital and Department of Preventive Cardiology, Institute of Clinical and Experimental Medicine, Prague, Czech Republic dPharmacology Department and INSERM U970 Hopital Europeen Georges Pompidou, Assistance Publique Hopitaux de Paris, Paris Derscartes University, France eDepartment of Hypertension and Diabetology, Medical University of Gdansk, Gdansk, Poland fInternal Medicine, Hospital Clinico, University of Valencia, Valencia, Spain gIRCCS MultiMedica, Sesto San Giovanni, Milan, Italy
    J Hypertens 31:2018-24. 2013
    ..The Blood Pressure (BP) control rate and CArdiovascular Risk profilE (BP-CARE) study allowed us to assess the prevalence and the main clinical features of resistant hypertension in this population...
  7. ncbi Factors related to the impact of antihypertensive treatment in antioxidant activities and oxidative stress by-products in human hypertension
    Guillermo T Saez
    Department of Biochemistry and Molecular Biology, Medical School, Valencia, Spain
    Am J Hypertens 17:809-16. 2004
    ..In conclusion, antihypertensive treatment improved the increased oxidative stress and the decreased antioxidant mechanisms. It is independent of the type of treatment and the beneficial effect of treatment increases over time...
  8. doi Added impact of obesity and insulin resistance in nocturnal blood pressure elevation in children and adolescents
    Empar Lurbe
    Pediatric Department, Consorcio Hospital General, University of Valencia, Valencia, Spain
    Hypertension 51:635-41. 2008
    ....
  9. doi Polymorphisms of antioxidant enzymes, blood pressure and risk of hypertension
    Maria L Mansego
    Genotyping and Genetic Diagnosis Unit, Hospital Clínico Research Foundation and INCLIVA, Valencia, Spain
    J Hypertens 29:492-500. 2011
    ..To assess the association of single-nucleotide polymorphisms (SNPs) in genes codifying for antioxidant enzymes to blood pressure (BP) values and risk of hypertension...
  10. doi Influence of concurrent obesity and low birth weight on blood pressure phenotype in youth
    Empar Lurbe
    Department of Pediatrics, Consorcio Hospital General, University of Valencia, Valencia, Spain
    Hypertension 53:912-7. 2009
    ..005) existed. In conclusion, although the low birth weight children who become obese have the highest systolic BP values, the presence of obesity blunts the increment of the reflecting wave observed in low birth weight subjects...
  11. ncbi Mechanisms of hypertension in the cardiometabolic syndrome
    Josep Redon
    University of Valencia, CIBER 06 03 Fisiopatología de la Obesidad y Nutrición, Institute of Health Carlos III, Madrid, Spain
    J Hypertens 27:441-51. 2009
    ....
  12. doi The impact of occult renal failure on the cardiovascular risk stratification in an elderly population: the PREV-ICTUS study
    Josep Redon
    Hypertension Clinic, Hospital Clinico Universitario, Universidad de Valencia, Spain
    Blood Press 17:212-9. 2008
    ..To analyze the impact of occult renal failure (ORF) in the individual risk stratification and on the blood pressures (BP) and low-density lipoprotein (LDL) goals in an aged population, according to the ESH/ESC Hypertension Guidelines...
  13. ncbi Metabolic syndrome, organ damage and cardiovascular disease in treated hypertensive patients. The ERIC-HTA study
    Jorge Navarro
    Salvador Pau Heath Care Center, Valencia, Spain
    Blood Press 16:20-7. 2007
    ....
  14. ncbi [Prevalence of low glomerular filtration rate in the elderly population of Spain. The PREV-ICTUS study]
    Luis Cea-Calvo
    Departamento de Investigación Clínica, Merck Sharp and Dohme de Espana, Madrid, Spain
    Med Clin (Barc) 129:681-7. 2007
    ..To assess the prevalence of low glomerular filtration rate (GFR < 60 ml/min/1.73 m2) in general population of subjects aged 60 years or older of Spain, and the related factors...
  15. doi Serum lipid profiles and their relationship to cardiovascular disease in the elderly: the PREV-ICTUS study
    Jose V Lozano
    Serrería 2 Health Center, Valencia, Spain
    Curr Med Res Opin 24:659-70. 2008
    ..To assess the relationship between different serum lipid profiles and the prevalence of established cardiovascular disease (CVD) in an elderly population...
  16. ncbi Differences in blood pressure control and stroke mortality across Spain: the Prevención de Riesgo de Ictus (PREV-ICTUS) study
    Josep Redon
    Hypertension Clinic, Hospital Clinico Universitario, Universidad de Valencia, Spain
    Hypertension 49:799-805. 2007
    ..Differences in stroke mortality throughout the autonomic communities of Spain were associated with indexes of worse blood pressure handling, low control rates, and high left-ventricular hypertrophy...
  17. ncbi Determinants of urinary albumin excretion reduction in essential hypertension: A long-term follow-up study
    Jose Maria Pascual
    Hypertension Clinics of Sagunto Hospital, University of Valencia, Spain
    J Hypertens 24:2277-84. 2006
    ..The objective of the present study was to assess factors related to long-term changes in urinary albumin excretion (UAE) of nondiabetic microalbuminuric (n = 252) or proteinuric hypertensive individuals (n = 58) in a prospective follow-up...
  18. doi Physician attitudes to blood pressure control: findings from the Supporting Hypertension Awareness and Research Europe-wide survey
    Josep Redon
    Hospital Clinico, University of Valencia, Valencia, Spain
    J Hypertens 29:1633-40. 2011
    ..The Supporting Hypertension Awareness and Research Europe-wide (SHARE) physician survey aimed to qualify the key challenges that physicians face when trying to get patients to blood pressure (BP) goal...
  19. ncbi Impact of obesity-related genes in Spanish population
    Fernando Martinez-Garcia
    Hypertension Clinic, Hospital Clínico Universitario and INCLIVA, University of Valencia, Valencia 46010, Spain
    BMC Genet 14:111. 2013
    ..Genotyping was assessed by using SNPlex and PLINK for the association analysis...
  20. ncbi [Prevalence of atrial fibrillation in the Spanish population aged 60 years or more. The PREV-ICTUS study]
    Luis Cea-Calvo
    Departamento de Investigación Clínica, Merck Sharp and Dohme de Espana, Madrid, Spain
    Rev Esp Cardiol 60:616-24. 2007
    ..The aims of this study were to determine the prevalence of atrial fibrillation in individuals aged 60 years or more in Spain using a random sample of the population and to identify associated factors...
  21. doi Blood pressure and obesity exert independent influences on pulse wave velocity in youth
    Empar Lurbe
    Department of Pediatrics, Consorcio Hospital General, University of Valencia, Avda Tres Cruces s n, 46014 Valencia, Spain
    Hypertension 60:550-5. 2012
    ..Furthermore, obesity, the factor most frequently related to essential hypertension in adolescents, blunted the expected increment in PWV of hypertensive and high-normal subjects...
  22. ncbi The impact of the degree of obesity on the discrepancies between office and ambulatory blood pressure values in youth
    Empar Lurbe
    Pediatric Nephrology and Cardiovascular Risk Unit, Consorcio Hospital General, University of Valencia, RECAVA, Spain
    J Hypertens 24:1557-64. 2006
    ..The impact of different degrees of obesity on BP and heart rate variability was also investigated...
  23. doi Special considerations for antihypertensive agents in dialysis patients
    Josep Redon
    Hypertension Clinic, Hospital Clinico, University of Valencia, Valencia, Spain
    Blood Purif 29:93-8. 2010
    ..Thus, antihypertensive regimens should preferably be based on these classes of drugs, alone or in combination. Other antihypertensive drug classes can play a complementary role...
  24. ncbi The effects of telmisartan alone or in combination with hydrochlorothiazide on morning home blood pressure control: the SURGE 2 practice-based study
    Josep Redon
    Hypertension Clinic, Hospital Clinico, INCLIVA, University of Valencia, and CIBER of Obesity and Nutrition CB06 03, Institute of Health Carlos III, Spain
    Blood Press 22:377-85. 2013
    ..4-87.0% (diastolic BP). Adverse events were reported by 1.2% of patients. Telmisartan alone or with HCTZ improved morning HBP control and maintained a smooth HBP profile throughout the day in a real-life setting...
  25. doi Regression of left ventricular hypertrophy and microalbuminuria changes during antihypertensive treatment
    Enrique Rodilla
    Hypertension Clinics of Sagunto Hospital bHospital Clinico, University of Valencia, Valencia, Spain
    J Hypertens 31:1683-91. 2013
    ..The objective of the present study was to assess the regression of left ventricular hypertrophy (LVH) during antihypertensive treatment, and its relationship with the changes in microalbuminuria...
  26. ncbi Discordant response of glutathione and thioredoxin systems in human hypertension?
    Maria L Mansego
    Laboratorio de Estudios Genéticos Fundación para la Investigación del Hospital Clínico, Valencia, Spain
    Antioxid Redox Signal 9:507-14. 2007
    ..We noted a discordant response of the glutathione and thioredoxin systems in essential hypertension and to antihypertensive treatment. Further studies examining the significance of these thiols in hypertension outcomes are warranted...
  27. ncbi Xanthine oxidoreductase polymorphisms: influence in blood pressure and oxidative stress levels
    Felipe J Chaves
    Genetic Studies Laboratory, Research Foundation of Clinic University Hospital of Valencia, Valencia, Spain
    Pharmacogenet Genomics 17:589-96. 2007
    ..We analyzed the association between the -337GA and 565+64CT polymorphisms of the xanthine oxidoreductase gene with blood pressure and oxidative stress levels...
  28. pmc Common variants of the liver fatty acid binding protein gene influence the risk of type 2 diabetes and insulin resistance in Spanish population
    Maria Luisa Mansego
    Genotyping and Genetic Diagnosis Unit, Fundación de Investigación del Hospital Clínico de Valencia INCLIVA, Valencia, Spain
    PLoS ONE 7:e31853. 2012
    ..The association was replicated in a second population in which HOMA index was also evaluated...
  29. doi Polymorphisms of the UCP2 gene are associated with body fat distribution and risk of abdominal obesity in Spanish population
    Sergio Martinez-Hervas
    Service of Endocrinology and Nutrition, Hospital Clinico Universitario de Valencia, Department of Medicine, University of Valencia, Valencia, Spain
    Eur J Clin Invest 42:171-8. 2012
    ..Our aim was to investigate the possible association of genetic variations of the gene codifying the UCP2 protein with obesity and fat distribution...
  30. doi Diagnosis and treatment of hypertension in children
    Empar Lurbe
    Cardiovascular Risk Unit, Hospital General, University of Valencia, Avda Tres cruces 2, 46014 Valencia, Spain
    Curr Hypertens Rep 12:480-6. 2010
    ..In the case of secondary hypertension, pharmacologic treatment usually is required. In essential hypertension, assessment of early organ damage provides a useful tool for treatment decisions...
  31. ncbi First-year blood pressure increase steepest in low birthweight newborns
    Empar Lurbe
    Pediatric Nephrology and Cardiovascular Risk Unit, Departement of Pediatrics, Consorcio Hospital General, University of Valencia, Avda Tres Cruces s n, 46014 Valencia, Spain
    J Hypertens 25:81-6. 2007
    ..The present research has been undertaken prospectively to study the impact of birthweight and growth pattern on blood pressure changes from birth through the first year of life...
  32. doi Increased oxidative stress levels and normal antioxidant enzyme activity in circulating mononuclear cells from patients of familial hypercholesterolemia
    Jose T Real
    Service of Endocrinology and Nutrition, Hospital Clinico Universitario, Department of Medicine, University of Valencia, 46010 Valencia, Spain
    Metabolism 59:293-8. 2010
    ..These data show an important alteration of OS regulation in FH and the absence of antioxidant response in CMCs mediated by some of the major antioxidant enzymes...
  33. doi Role of dihydropyridinic calcium channel blockers in the management of hypertension
    Antonio Coca
    Department of Internal Medicine, Hypertension Unit, Institute of Medicine and Dermatology, Hospital Clinico, University of Barcelona, Barcelona, Spain
    Expert Rev Cardiovasc Ther 11:91-105. 2013
    ..Therefore, in the light of new studies that include calcium channel blockers alone or in combination, these agents will probably be used even more extensively for the management of hypertension in the following years...
  34. doi Safety and efficacy of low blood pressures among patients with diabetes: subgroup analyses from the ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial)
    Josep Redon
    CIBEROBN, Institute of Health Carlos III, Hospital Clinico Universitario, INCLIVA, Valencia, Spain
    J Am Coll Cardiol 59:74-83. 2012
    ....
  35. doi Impact of cardiovascular risk factors on oxidative stress and DNA damage in a high risk Mediterranean population
    Marta Fandos
    Department of Biochemistry and Molecular Biology, Faculty of Medicine, School of Medicine, University of Valencia, Valencia, Spain
    Free Radic Res 43:1179-86. 2009
    ..Among the main cardiovascular risk factors, hypertension was the strongest determinant of oxidative stress in high risk subjects studied at a primary prevention stage...
  36. ncbi Urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxo-dG), a reliable oxidative stress marker in hypertension
    Olga Espinosa
    Oxidative Pathology Unit, Department of Biochemistry and Molecular Biology, School of Medicine, University of Valencia, Valencia, Spain
    Free Radic Res 41:546-54. 2007
    ..Moreover, urinary excretion of 8-oxo-dG also correlates with the GSSG/GSH ratio of cells. Conclusion: urine 8-oxo-dG assay is a good marker for monitoring oxidative stress changes in hypertensives...
  37. doi Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension
    Empar Lurbe
    Department of Pediatrics, Consorcio Hospital General, University of Valencia, Spain
    J Hypertens 27:1719-42. 2009
    ....
  38. ncbi Hypertension in the metabolic syndrome: summary of the new position statement of the European Society of Hypertension
    Josep Redon
    Hypertension Clinic, Internal Medicine, Hospital Clinico, University of Valencia, Valencia, Spain
    Pol Arch Med Wewn 119:255-60. 2009
    ..The effect of particular antihypertensive drugs on other components of the MS is an important clinical issue with consequences for the success of the treatment...
  39. ncbi Long-term impact of systolic blood pressure and glycemia on the development of microalbuminuria in essential hypertension
    Jose Maria Pascual
    Hypertension Clinics, Sagunto Hospital, University of Valencia, Valencia, Spain
    Hypertension 45:1125-30. 2005
    ..In mild hypertensives, the development of microalbuminuria was linked to insufficient blood pressure control and to a progressive increment of glucose values...
  40. doi Sexual dimorphism in the transition from masked to sustained hypertension in healthy youths
    Empar Lurbe
    Department of Pediatrics, Consorcio Hospital General, University of Valencia, Avda Tres Cruces s n, 46014 Valencia, Spain
    Hypertension 62:410-4. 2013
    ..The risk of developing sustained hypertension is higher in boys than it is for girls. The fact that masked hypertension is not prognostically innocent increases the importance of the diagnosis at an early age...
  41. doi Stroke mortality and trends from 1990 to 2006 in 39 countries from Europe and Central Asia: implications for control of high blood pressure
    Josep Redon
    Hypertension Clinic, Hospital Clinico, University of Valencia INCLIVA and CIBERObn Institute of Health Carlos III, Avda Blasco Ibanez, 17, 46010 Madrid, Spain
    Eur Heart J 32:1424-31. 2011
    ....
  42. ncbi The impact of birth weight on pulse pressure during adolescence
    Empar Lurbe
    Pediatric Nephrology Unit, Department of Paediatrics, General Hospital, University of Valencia, Spain
    Blood Press Monit 9:187-92. 2004
    ..The objective was to study the influence of birth weight on office and ambulatory pulse pressure...
  43. ncbi Factors associated with therapeutic inertia in hypertension: validation of a predictive model
    Josep Redon
    Unidad de Hipertension, Servicio de Medicina Interna, Hospital Clinico, Universidad de Valencia y CIBERON, Instituto de Salud Carlos III, Madrid, Spain
    J Hypertens 28:1770-7. 2010
    ....
  44. ncbi Genetic bases of urinary albumin excretion and related traits in hypertension
    Fernando Martinez
    Hypertension Clinic, Internal Medicine, Hospital Clinico, University of Valencia, Avda Blasco Ibanez, 17, E 46010 Valencia, Spain
    J Hypertens 28:213-25. 2010
    ..Combined strategies can contribute toward a better understanding of the genetic basis of urinary albumin excretion and renal damage in hypertension..
  45. doi Association of a mineralocorticoid receptor gene polymorphism with hypertension in a Spanish population
    Fernando Martinez
    Hypertension Clinic, Hospital Clinico Universitario, University of Valencia, Valencia, Spain
    Am J Hypertens 22:649-55. 2009
    ..To assess the association of polymorphisms and haplotypes of the mineralocorticoid receptor (MR) (NR3C2) gene to the risk of essential hypertension (HTN) in a Spanish population...
  46. doi The importance of 24-hour ambulatory blood pressure monitoring in patients at risk of cardiovascular events
    Josep Redon
    Internal Medicine, Hospital Clinico, INCLIVA, University of Valencia, Valencia, Spain
    High Blood Press Cardiovasc Prev 20:13-8. 2013
    ..When choosing an antihypertensive agent for patients with hypertension, it is important to consider reducing BP variability by using longer acting antihypertensives, which may help to prevent cardiovascular morbidity and mortality...
  47. doi Efficacy of combination therapy with angiotensin-converting enzyme inhibitor and calcium channel blocker in hypertension
    Josep Redon
    Internal Medicine, Hospital Clinico de Valencia, University of Valencia, Avda Blasco Ibanez 17, 46010 Valencia, Spain
    Expert Opin Pharmacother 14:155-64. 2013
    ..Combined therapies containing an angiotensin-converting enzyme inhibitor (ACEI) with a calcium channel blocker (CCB) is one of the recommended combinations in the reappraisal of the European Society of Hypertension...
  48. ncbi Home blood pressure control is low during the critical morning hours in patients with hypertension: the SURGE observational study
    Josep Redon
    Hypertension Clinic, Department of Internal Medicine, Hospital Clinico, University of Valencia, Valencia, Spain
    Fam Pract 29:421-6. 2012
    ..The morning blood pressure (BP) surge is associated with a peak increase in vascular events...
  49. ncbi Blood pressure control and stroke mortality across populations
    Josep Redon
    Hypertension Clinic, Internal Medicine Department, Hospital Clinico, University of Valencia, 46010 Valencia, Spain
    Curr Hypertens Rep 9:440-1. 2007
  50. doi Nocturnal blood pressure and progression to end-stage renal disease or death in nondiabetic chronic kidney disease stages 3 and 4
    Josep Redon
    Hypertension Clinic, Internal Medicine, Hospital Clinico, University of Valencia, Valencia, Spain
    J Hypertens 28:602-7. 2010
    ..The objective was to assess the role of office and ambulatory blood pressure (BP) on the development of end-stage renal disease (ESRD) in nondiabetic chronic renal failure...
  51. ncbi The metabolic syndrome in hypertension: diagnostic and therapeutic implications
    Josep Redon
    Hypertension Clinic, Internal Medicine, Hospital Clinico, University of Valencia, 46010 Valencia, Spain
    Curr Hypertens Rep 9:305-13. 2007
    ..The impact of particular antihypertensive drugs on other components of the metabolic syndrome is an important clinical issue with consequences for the success of treatment...
  52. ncbi Effectiveness of an Interventional Program to Improve Blood Pressure Control in Hypertensive Patients at High Risk for Developing Heart Failure: HEROIC study
    Beatriz de Rivas
    Medical Department, AstraZeneca, Madrid, Spain
    J Clin Hypertens (Greenwich) 12:335-44. 2010
    ..More complex and intensive programs are needed for this type of prevention...
  53. ncbi Antihypertensive activity of angiotensin II AT1 receptor antagonists: a systematic review of studies with 24 h ambulatory blood pressure monitoring
    Maria Jose Fabia
    Hypertension Clinic, Internal Medicine, Hospital Clinico Universitario, Universidad de Valencia, Valencia, Spain
    J Hypertens 25:1327-36. 2007
    ..To perform a systematic review of the antihypertensive activity of the angiotensin II AT1 receptor antagonists (ARB)...
  54. ncbi Associations of birth weight and postnatal weight gain with cardiometabolic risk parameters at 5 years of age
    Empar Lurbe
    Department of Pediatrics, Consorcio Hospital General, University of Valencia, Avda Tres Cruces s n, 46014 Valencia, Spain
    Hypertension 63:1326-32. 2014
    ..In conclusion, the acceleration of early infant weight gain may aggravate the effects of low BW. Multiple interactions between hemodynamic and metabolic parameters foreshadow the clustering of cardiometabolic risk factors later in life. ..
  55. doi Prevalence and factors related to urinary albumin excretion in obese youths
    Empar Lurbe
    aPediatric Department, Consorcio Hospital General, University of Valencia, Valencia bCIBER Fisiopatología Obesidad y Nutrición CB06 03, Instituto de Salud Carlos III, Madrid cInternal Medicine, Hospital Clinico, INCLIVA, University of Valencia, Valencia, Spain
    J Hypertens 31:2230-6; discussion 2236. 2013
    ..The aim of the present study is to assess whether obesity is associated with urinary albumin excretion and what the main determinants are...
  56. ncbi [Factors related to the differences in blood pressure values assessed by auscultatory or oscillometric methods]
    María Rosa Oltra
    Unidad de Hipertension Arterial, Servicio de Medicina Interna, Hospital Clinic Universitari, Universitat de Valencia, Valencia, Spain
    Med Clin (Barc) 127:688-91. 2006
    ..Discrepancies between the two methods and the factors related to them were analyzed in a large subset of adults...
  57. doi Microalbuminuria as surrogate endpoint in therapeutic trials
    Josep Redon
    Hypertension Clinic, Hospital Clinico of Valencia and Research Institute INCLIVA, University of Valencia and CIBERObn, Instituto de Salud Carlos III, Madrid, Spain
    Curr Hypertens Rep 14:345-9. 2012
    ..The most appropriate timing with which to repeat microalbuminuria and whether or not changes should be targeted during the antihypertensive treatment remain unanswered...
  58. ncbi Urinary albumin excretion and glomerular filtration rate across the spectrum of glucose abnormalities in essential hypertension
    Josep Redon
    Hypertension Clinic, Internal Medicine Service, Hospital Clinico, University of Valencia, 46010 Valencia, Spain
    J Am Soc Nephrol 17:S236-45. 2006
    ..29 to 2.04). There is a close relationship between abnormal UAE and renal insufficiency in essential hypertension. This is more marked in patients with diabetes and moderate in patients with high-range impaired fasting glucose...
  59. ncbi Factors related to the occurrence of microalbuminuria during antihypertensive treatment in essential hypertension
    Josep Redon
    Hypertension Clinic, Hospital Clinico, University of Valencia, Valencia, Spain
    Hypertension 39:794-8. 2002
    ....
  60. ncbi Antihypertensive treatment: should it be titrated to blood pressure reduction or to target organ damage regression?
    Josep Redon
    Hypertension Clinic, Hospital Clinico, University of Valencia, Avda Blasco Ibanez 17, 46010 Valencia, Spain
    Curr Opin Nephrol Hypertens 14:448-52. 2005
    ..Moreover, monitoring intermediate objectives may provide scientific evidence for delineating the best antihypertensive treatment...
  61. ncbi Predictors of progression in hypertensive renal disease in children
    Empar Lurbe
    Pediatric Nephrology Unit, Hospital General, University of Valencia, Avenida Tres Cruces s n, 46014 Valencia, Spain
    J Clin Hypertens (Greenwich) 6:186-91. 2004
    ..It should be reduced as much as possible to obtain maximal renoprotective effect. The role of the other factors, such as lipid disorders and genetics, remains elusive...
  62. ncbi Reversible posterior leukoencephalopathy secondary to indinavir-induced hypertensive crisis: a case report
    Vicente Giner
    Internal Medicine Department, Hospital Clinico Universitario, University of Valencia, Spain
    Am J Hypertens 15:465-7. 2002
    ..The clinical and radiologic evolution excludes other diagnosis as progressive multifocal leukoencephalopathy and points indinavir as a potential hypertension-inducing agent in HIV-infected predisposed subjects...
  63. ncbi Thrombocytopenia associated with levodopa treatment
    Vicente Giner
    Department of Internal Medicine, Hospital Clinico Universitario, Valencia, Spain
    Arch Intern Med 163:735-6. 2003
  64. ncbi Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes
    Empar Lurbe
    Pediatric Nephrology Unit, Department of Pediatrics, Hospital General and University of Valencia, Valencia, Spain
    N Engl J Med 347:797-805. 2002
    ..Patients with type 1 diabetes mellitus and microalbuminuria often have elevated blood pressure while they are asleep, but it is not known whether the elevation develops concomitantly with microalbuminuria or precedes it...
  65. ncbi Birth weight impacts on wave reflections in children and adolescents
    Empar Lurbe
    Pediatric Nephrology Unit, Department of Pediatrics, General Hospital, University of Valencia, Avda Tres Cruces s n, 46014 Valencia, Spain
    Hypertension 41:646-50. 2003
    ..These early alterations may be amplified throughout life and may contribute to the increased cardiovascular risk associated with low birth weight...
  66. ncbi Managing resistant hypertension: not just a question of numbers
    Josep Redon
    Hypertension Clinic, Internal Medicine, Hospital Clinico, RECAVA, University of Valencia, Valencia, Spain
    Am J Hypertens 18:1541-2. 2005
  67. ncbi Development of microalbuminuria in essential hypertension
    Josep Redon
    Hypertension Clinic, Internal Medicine, Hospital Clinico, Avda Blasco Ibanez, 17, 46010 Valencia, Spain
    Curr Hypertens Rep 8:171-7. 2006
    ..Whether or not the multiple approaches need to be implemented from the beginning or step by step in an individual approach should be established in the near future...
  68. pmc Cardiovascular risk reduction by reversing endothelial dysfunction: ARBs, ACE inhibitors, or both? Expectations from the ONTARGET Trial Programme
    Luis Miguel Ruilope
    Servicio de Nefrologia, Unidad de Hipertension Hospital, 12 de Octubre, Madrid, Spain
    Vasc Health Risk Manag 3:1-9. 2007
    ..Completion of ONTARGET is expected in 2008...
  69. ncbi Inadequate cytoplasmic antioxidant enzymes response contributes to the oxidative stress in human hypertension
    Felipe J Chaves
    Research Unit, Hospital Clinico Universitario, University of Valencia, Avenida Blasco Ibañez 17, 46010 Valencia, Spain
    Am J Hypertens 20:62-9. 2007
    ..The inadequate response of the main cytoplasmatic antioxidant systems, as well as of the enzymes participating in the maintenance of glutathione levels, may contribute to the vulnerability of hypertensives to oxidative stress...
  70. doi Efficacy in angiotensin receptor blockade: a comparative review of data with olmesartan
    Josep Redon
    Hypertension Clinic, Hospital Clinico Universitario, University of Valencia, Valencia, Spain
    J Renin Angiotensin Aldosterone Syst 10:147-56. 2009
    ....
  71. ncbi [Risk assessment for a first stroke in Spanish hypertensive population in primary care. The ERIC-HTA study]
    Jose V Lozano
    Centro de Salud Serrería 2, Valencia, Spain
    Med Clin (Barc) 125:247-51. 2005
    ..Stroke is a major cause of morbidity and mortality in hypertensive population. The aim of this study is to estimate the 10-year risk of a first stroke in Spanish hypertensive population using the Framingham scale...
  72. ncbi Uncontrolled early morning blood pressure in medicated patients: the ACAMPA study. Analysis of the Control of Blood Pressure using Abulatory Blood Pressure Monitoring
    Josep Redon
    Hypertension Clinic, Hospital Clinico, University of Valencia, Valencia, Spain
    Blood Press Monit 7:111-6. 2002
    ..The objective of this study was thus to assess the blood pressure behaviour profile of early morning blood pressure in patients receiving antihypertensive treatment...